Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ulcerative colitis
ulcerative colitis
Roche’s test of novel gut target nears
EP Vantage
Tue, 05/12/20 - 11:39 am
Roche
ulcerative colitis
etrolizumab
Takeda
Entyvio
Upcoming events – Filgotinib's ulcerative colitis data and serlopitant takes on pruritus
EP Vantage
Fri, 02/21/20 - 10:35 am
Gilead Sciences
Galapagos
filgotinib
ulcerative colitis
Menlo Therapeutics
serlopitant
Celltrion showcases positive one-year results for subcutaneous formulation of infliximab in patients with active Crohn’s disease and ulcerative colitis
Pharmaceutical Business Review
Mon, 02/17/20 - 10:20 am
Celltrion
clinical trials
CT-P13
Crohn's Disease
ulcerative colitis
FDA Approves Pfizer's Extended Release Xeljanz for Ulcerative Colitis
BioSpace
Fri, 12/13/19 - 12:21 pm
Pfizer
Xeljanz XR
FDA
ulcerative colitis
Pfizer's Xeljanz gets EMA blood clots warning following FDA's similar move
Fierce Pharma
Sat, 11/16/19 - 10:27 pm
Europe
EMA
ulcerative colitis
Pfizer
Xeljanz
Janssen’s Stelara Wins FDA Approval for Ulcerative Colitis
BioSpace
Mon, 10/21/19 - 04:45 pm
JNJ
Janssen
Stelara
FDA
ulcerative colitis
InDex's topical ulcerative colitis drug hits goal in phase 2b
Fierce Biotech
Tue, 08/27/19 - 09:33 am
InDex Pharmaceuticals
ulcerative colitis
TLR-9
$60M B round to propel Landos through Phase II IBD trials
BioCentury
Wed, 08/14/19 - 11:07 am
Landos Biopharma
clinical trials
ulcerative colitis
Crohn's Disease
BT-11
Microbiome-Focused Seres Therapeutics Inc. Announces Proposed Common Stock Offering
CP Wire
Thu, 06/13/19 - 09:56 am
Seres Therapeutics
C. difficile
ulcerative colitis
Microbiome-Focused Seres Therapeutics Inc. Announces Proposed Common Stock Offering
Thu, 06/13/19 - 09:54 am
Seres Therapeutics
C. difficile
ulcerative colitis
Salix grabs ex-Asia rights to Mitsubishi Tanabe autoimmune drug
Fierce Biotech
Thu, 04/25/19 - 10:37 am
Salix
Mitsubishi Tanabe Pharma
amiselimod
Bausch Health
autoimmune disease
ulcerative colitis
Takeda’s Entyvio Bests Humira in Head-to-Head UC Study
BioSpace
Mon, 03/11/19 - 10:25 am
Takeda
Entyvio
AbbVie
Humira
ulcerative colitis
Pfizer drops higher dose treatment arm in Xeljanz post-marketing study due to safety issues
CP Wire
Wed, 02/20/19 - 11:52 am
Pfizer
Xeljanz
post-marketing studies
FDA
rheumatoid arthritis
ulcerative colitis
Pfizer drops higher dose treatment arm in Xeljanz post-marketing study due to safety issues
Wed, 02/20/19 - 11:51 am
Pfizer
Xeljanz
post-marketing studies
FDA
rheumatoid arthritis
ulcerative colitis
Takeda is ready to auction off a PhIII favorite at Shire to clear the last hurdles to a $62B buyout
Enpoints
Sun, 10/28/18 - 07:47 pm
Takeda
Shire
inflammatory bowel disease
IBD
ulcerative colitis
Crohn's Disease
M&A
SHP647
J&J's Stelara succeeds in chronic bowel disease study
Yahoo/Reuters
Tue, 10/9/18 - 11:21 am
JNJ
Stelara
ulcerative colitis
Abivax Bolstered by Positive Mid-Stage Results from Ulcerative Colitis Treatment
BioSpace
Tue, 09/4/18 - 11:22 pm
Abivax
ulcerative colitis
ABX464
Takeda Drug Achieves Primary Endpoint of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
CP Wire
Thu, 07/19/18 - 11:20 am
Takeda
vedolizumab
ulcerative colitis
Entyvio
Takeda Drug Achieves Primary Endpoint of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
Thu, 07/19/18 - 10:07 am
Takeda
Entyvio
ulcerative colitis
Chron's Disease
Landos Biopharma Initiates Ph I Trial of First-in-class Oral Treatment for IBD
Thu, 07/12/18 - 09:17 am
Landos Biopharma
ulcerative colitis
Chron's Disease
IBD
BT-11
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »